400-1022-688
Cardiac disease diagnosis

cTnI Test Kit

Time-Resolved Fluorescent Immunochromatographic Assay



【General Information】

1.Method: Time-resolved Fluorescent Immunochromatographic Method 

2.Bio-marker tested: cardiac troponin I (cTnI)  

3.Clinical Sample: whole blood or fingernail blood, serum or plasma 

4.Other Specifications: in vitro, quantitative test 


【Clinical significance】

1. "Golden Standard" to diagnose myocardial infarction (MI) 

2. Assess infarct size and ACS risks 

3. Bio-marker for monitoring the treatment of AMI 


【Advantages】

1. Advanced: time-resolved fluorescence immunoassay quantitative chromatography 

2. Quantitative: quantitative detection of myocardial infarction marker cardiac troponin I (cTnI) 

3. Accurate: well correlated with imported chemiluminescence reagent (r> 0.975)  

4. High sensitivity: lower detection limit <0.05 ng/mL  

5. Simple: simple operation, suitable for bedside detection 

6. Widely applicable : outpatient laboratory, emergency laboratory, medical center, cardiology, ICU, and etc 




Top

Earlier
Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment